The recently released "13th Five-Year Plan" clearly pointed out that the promotion of localization of medical devices, and the emphasis on domestic medical devices need to be high-end, branded development. Accelerating the localization of high-end medical devices is one of the key points in the development of the entire medical system in China. The recently launched “13th Five-Year Plan†has made clear instructions for promoting the localization of medical devices, and it is emphasized that domestic medical devices need to be high-end. The path of brand development. We believe that in the context of policy promotion and medical insurance control fees, with the improvement of the technical level of localized medical devices, domestic high-end and brand medical devices will be recognized by more people, and will accelerate the replacement of leading foreign brands. In this context, the author conducted an exclusive interview with the co-founder and operation director of the company, Mr. Garden, for the development of domestic high-end medical devices. Interviewed by Ms. Pastoral, she started her career in the GE Ultrasound R&D team in June 2003. In 2010, she formed the Feyino team and became the co-founder. Why is Feiyin positioned as a high-end ultrasound diagnostic equipment? Pastoral: Feiyinuo was established in 2010. The initial position of entrepreneurship is to do high-end ultrasound, mainly for two reasons. First of all, the high-end market is basically monopolized by imported brands, and monopoly means high profits; In addition, many domestic brands have already laid out the low-end market, and brand accumulation has already taken shape. If they repeat their path, the company does not have a special competitive advantage. Positioning the high-end market is a huge challenge for both R&D and sales markets. Of course, this also contains huge opportunities. What difficulties have you encountered in making high-end medical equipment made in China? Pastoral: It took almost 4 years from the establishment of the company to the start of sales. In order to have better image quality, we developed the RF metadata platform. This platform is relatively stable until 2013, and the research and development cycle is nearly 4 years. Time is far beyond the original plan, which is also the risk of positioning high-end. After the product came out, our goal was to compete directly with the top three hospitals and GPS, but there was almost no sales in the first half of the year. The reason is that the customer is not fully understood, and the market is not expected to react so coldly. With the continuous development of technology over the past few years, the products have passed the trial and feedback in the hospital, the experts began to accept and agree with our products, and under the strong promotion of the country, this process is also accelerating, we are lucky to catch up with the domestic The trend of change. King Oyster Mushroom,King Trumpet Mushrooms,French Horn Mushrooms,Oyster Mushrooms Guangyun Agricultural Biotechnology (Jiangsu) Co., Ltd , https://www.7-mushrooms.com.jpg)